In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


The free consultation period for this content is over.

It is now only available year-round to EAPC Ivory (& above) Members, Fellows of the ESC and Young combined Members

Awareness about target levels of cardiovascular risk factors in different types of hospitalized medical patients

Session Poster Session 2

Speaker Nana Goar Pogosova

Congress : ESC Preventive Cardiology (Formerly EuroPrevent) 2019

  • Topic : preventive cardiology
  • Sub-topic : Secondary Prevention
  • Session type : Poster Session
  • FP Number : P534

Authors : N Pogosova (Moscow,RU), YM Yufereva (Moscow,RU), AV Karpova (Moscow,RU), SS Isakova (Moscow,RU), VA Vygodin (Moscow,RU), MA Lysenko (Moscow,RU), IV Samsonova (Moscow,RU)

Authors:
N Pogosova1 , YM Yufereva1 , AV Karpova2 , SS Isakova1 , VA Vygodin2 , MA Lysenko3 , IV Samsonova3 , 1National Medical Research Center of Cardiology - Moscow - Russian Federation , 2National Center for Preventive Medicine - Moscow - Russian Federation , 3City Hospital 52 - Moscow - Russian Federation ,

Citation:

Background: Patients’ (pts) awareness of about target levels of risk factors (RFs) is important for their treatment adherence and self-management skills.
Objective: To study awareness of target levels of cardiovascular RFs in hospitalized pts with cerebrovascular, endocrine and cardiac conditions.
Methods: A total of 150 pts from neurology (NU), endocrine (EU) and cardiac (CU) units a Moscow city hospital were enrolled into the survey (n=50 for each unit). The pts were interviewed during the I-II days of the hospitalization using a dedicated questionnaire which included socio-demographic and clinical indicators, open questions on the awareness of traditional cardiovascular RFs and their target values.
Results: Pts from the 3 units did not differ in gender and age. The range of pts diagnoses corresponded to the department profile. 20% of NU pts were treated for acute stroke (6% of them - for recurrent stroke), 8% - for transient ischemic attacks and the remainder – for chronic neurological conditions.  60% of EU pts had type 2 diabetes mellitus. 62% of CU had various presentations of coronary heart disease, 84% had hypertension. The majority of pts from all units believed that they knew the target levels of cardiovascular RFs well. However, their real awareness was low. Only 12% of CU pts, 5% of EU pts and none NU pts indicated the normal level of total cholesterol (TC) correctly, and knowledge of appropriate physical activity (PA) level was poor as well. The participants knew blood pressure (BP) much better, but there was still a large room for improvement.
Conclusion: The survey revealed a low awareness of target levels  for cardiovascular RFs in different types of medical pts at time of hospital admission.

Proportion of NU pts, % Proportion of EU pts, % Proportion of CU pts, % Differences between NU and CU pts Differences between EU and CU pts
Reported that they knew the target level of:
Blood pressure

68.0

84.0 94.0 <0.001 NS
Total cholesterol 34.0 42.0

67.2

<0.01 <0.05
Physical activity 70.0 66.0 46.0 <0.05 <0.05
Actually knew the target level of:
Blood pressure 64.7

42.9

42.6 <0.05 NS
Total cholesterol 0

4.8

11.8 <0.05 NS
Physical activity 0 9.1 13.0 <0.01 NS
NU=Neurology unit, EU=Endocrine unit, CU=Cardiac unit, NS= not significant


Based on your interests

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are